Condition

Clinical Stage III Gastric Cancer AJCC v8

ClinicalTrials.gov condition label

Clinical trials6

Recruiting1

Common interventions21

Lead sponsors shown3

Clinical trials

6 shown

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsNCT05269381 · 2022-03-31

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerNCT04491942 · 2021-08-25

ACTIVE_NOT_RECRUITING

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialNCT04704661 · 2021-08-09

ACTIVE_NOT_RECRUITING

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsNCT04550494 · 2021-04-26

ACTIVE_NOT_RECRUITING

Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid TumorsNCT04007744 · 2020-02-13

ACTIVE_NOT_RECRUITING

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesNCT04501913 · 2019-12-24

Common interventions

Leading sponsors

National Cancer Institute (NCI)3 Mayo Clinic2 City of Hope Medical Center1

Trial status mix

ACTIVE_NOT_RECRUITING4

COMPLETED1

RECRUITING1

Phase mix

PHASE14

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.